These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 28373354
1. Protective Role for Macrophages in Respiratory Francisella tularensis Infection. Steiner DJ, Furuya Y, Jordan MB, Metzger DW. Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28373354 [Abstract] [Full Text] [Related]
2. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain. Skyberg JA, Rollins MF, Samuel JW, Sutherland MD, Belisle JT, Pascual DW. Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604 [Abstract] [Full Text] [Related]
3. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain. Cowley SC, Meierovics AI, Frelinger JA, Iwakura Y, Elkins KL. J Immunol; 2010 May 15; 184(10):5791-801. PubMed ID: 20393138 [Abstract] [Full Text] [Related]
4. Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS. López MC, Duckett NS, Baron SD, Metzger DW. Cell Immunol; 2004 May 15; 232(1-2):75-85. PubMed ID: 15922718 [Abstract] [Full Text] [Related]
5. Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis. Troyer RM, Propst KL, Fairman J, Bosio CM, Dow SW. Vaccine; 2009 Jul 16; 27(33):4424-33. PubMed ID: 19490961 [Abstract] [Full Text] [Related]
7. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. KuoLee R, Harris G, Conlan JW, Chen W. Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863 [Abstract] [Full Text] [Related]
13. Role of neutrophils and NADPH phagocyte oxidase in host defense against respiratory infection with virulent Francisella tularensis in mice. KuoLee R, Harris G, Conlan JW, Chen W. Microbes Infect; 2011 May 10; 13(5):447-56. PubMed ID: 21277990 [Abstract] [Full Text] [Related]
14. Restricted cytosolic growth of Francisella tularensis subsp. tularensis by IFN-gamma activation of macrophages. Edwards JA, Rockx-Brouwer D, Nair V, Celli J. Microbiology (Reading); 2010 Feb 10; 156(Pt 2):327-339. PubMed ID: 19926654 [Abstract] [Full Text] [Related]
15. Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections. Skyberg JA, Rollins MF, Holderness JS, Marlenee NL, Schepetkin IA, Goodyear A, Dow SW, Jutila MA, Pascual DW. PLoS Pathog; 2012 Feb 10; 8(3):e1002587. PubMed ID: 22438809 [Abstract] [Full Text] [Related]
16. Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia. Lembo A, Pelletier M, Iyer R, Timko M, Dudda JC, West TE, Wilson CB, Hajjar AM, Skerrett SJ. J Immunol; 2008 Jun 01; 180(11):7574-81. PubMed ID: 18490759 [Abstract] [Full Text] [Related]
19. IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection. Roberts LM, Davies JS, Sempowski GD, Frelinger JA. Vaccine; 2014 Jun 17; 32(29):3595-603. PubMed ID: 24837506 [Abstract] [Full Text] [Related]
20. Role of Interleukin-12 in Protection against Pulmonary Infection with Methicillin-Resistant Staphylococcus aureus. Nguyen QT, Furuya Y, Roberts S, Metzger DW. Antimicrob Agents Chemother; 2015 Oct 17; 59(10):6308-16. PubMed ID: 26248370 [Abstract] [Full Text] [Related] Page: [Next] [New Search]